Select a medication above to begin.
Veklury
remdesivir
Adult Dosing .
Dosage forms: INJ
COVID-19
- [mild-moderate]
- Dose: 200 mg IV x1, then 100 mg IV q24h x2 days; Start: ASAP w/in 7 days of sx onset; Info: for non-hospitalized pts at high risk for dz progression
- [severe]
- Dose: 200 mg IV x1, then 100 mg IV q24h x4 days; Info: for hospitalized pts >40 kg not requiring mechanical ventilation and/or ECMO; may give w/ baricitinib per baricitinib FDA Emergency Use Authorization; ECMO = extracorporeal membrane oxygenation
renal dosing
- [see below]
- renal impairment: no adjustment
- HD: no adjustment; no supplement; PD: not defined
hepatic dosing
- [no adjustment]
Peds Dosing .
- Dosage forms: INJ
COVID-19, mild-moderate
- [0-27 days old, >1.5 kg]
- Dose: 2.5 mg/kg/dose IV x1, then 1.25 mg/kg/dose IV q24h x2 days; Start: ASAP w/in 7 days of sx onset; Info: for non-hospitalized pts at high risk for dz progression; use IV powder form due to lower IV vehicle amt
- [28 days old and older, 1.5-2.9 kg]
- Dose: 2.5 mg/kg/dose IV x1, then 1.25 mg/kg/dose IV q24h x2 days; Start: ASAP w/in 7 days of sx onset; Info: for non-hospitalized pts at high risk for dz progression; use IV powder form due to lower IV vehicle amt
- [28 days old and older, 3-39 kg]
- Dose: 5 mg/kg/dose IV x1, then 2.5 mg/kg/dose IV q24h x2 days; Start: ASAP w/in 7 days of sx onset; Info: for non-hospitalized pts at high risk for dz progression; use IV powder form due to lower IV vehicle amt
- [28 days old and older, >40 kg]
- Dose: 200 mg IV x1, then 100 mg IV q24h x2 days; Start: ASAP w/in 7 days of sx onset; Info: for non-hospitalized pts at high risk for dz progression
COVID-19, severe
- [0-27 days old, >1.5 kg]
- Dose: 2.5 mg/kg/dose IV x1, then 1.25 mg/kg/dose IV q24h x4 days; Info: for hospitalized pts >40 kg not requiring mechanical ventilation and/or ECMO; may extend tx for up to 5 additional days if no clinical improvement; use IV powder form due to lower IV vehicle amt; ECMO = extracorporeal membrane oxygenation
- [28 days old and older, 1.5-2.9 kg]
- Dose: 2.5 mg/kg/dose IV x1, then 1.25 mg/kg/dose IV q24h x4 days; Info: for hospitalized pts >40 kg not requiring mechanical ventilation and/or ECMO; may give w/ baricitinib per baricitinib FDA EUA in pts 2 yo and older; may extend tx for up to 5 additional days if no clinical improvement; use IV powder form due to lower IV vehicle amt; ECMO = extracorporeal membrane oxygenation
- [28 days old and older, 3-39 kg]
- Dose: 5 mg/kg/dose IV x1, then 2.5 mg/kg/dose IV q24h x4 days; Info: for hospitalized pts >40 kg not requiring mechanical ventilation and/or ECMO; may give w/ baricitinib per baricitinib FDA EUA in pts 2 yo and older; may extend tx for up to 5 additional days if no clinical improvement; use IV powder form due to lower IV vehicle amt; ECMO = extracorporeal membrane oxygenation
- [28 days old and older, >40 kg]
- Dose: 200 mg IV x1, then 100 mg IV q24h x4 days; Info: for hospitalized pts >40 kg not requiring mechanical ventilation and/or ECMO; may give w/ baricitinib per baricitinib FDA EUA in pts 2 yo and older; may extend tx for up to 5 additional days if no clinical improvement; ECMO = extracorporeal membrane oxygenation
renal dosing
- [see below]
- renal impairment: no adjustment
- HD: no adjustment; no supplement; PD: not defined
hepatic dosing
- [no adjustment]